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Purpose: Histology plays a critical role in cartilage repair research. 
However, routine manual histoprocessing for orthopaedic tissues remains 
laborious, time-consuming and requires toxic chemicals. The current 
study investigated the ability of microwave technology (Milestone) to 
process osteochondral and synovial samples, and compared histological 
quality and reproducibility to standard manual histoprocessing. 
Methods and Materials: 8 rabbit femoral articular cartilage and patellar 
synovial tissue samples, and 3 human osteochondral samples were 
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samples were sectioned to 5 µm and either stained with Safranin-O/Fast 
Green or immunostained for collagen type II. Synovial sections were 
stained with H&E. 
Results: Microwave processing substantially decreased processing time 
from 46 to 3.25 hours for cartilage, and 8 to 3.25 hours for synovial tissue, 
without the use of toxic xylene and toluene. Both methods produced high 
quality tissue sections that underwent minimal shrinkage, contained 
very few artifacts, and did not exhibit swelling of connective tissue 
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characteristics and the subchondral bone contained osteoclasts with few 
morphological alterations. Cartilage GAG staining intensity observed with 
Safranin-O was reproducible for both histoprocessing methods, as was 
collagen type II staining. However, only microwave processing preserved 
bone marrow structures and allowed differentiation between marrow cell 
types. 
Conclusions: Microwave histoprocessing consistently produced high 
quality, reproducible and equivalent histological results when compared 
with routine manual histoprocessing for both osteochondral and synovial 
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through much shorter histoprocessing times in a safer environment. 
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Purpose: To evaluate the effect of intraarticular injections of growth 
hormone and insulin-like growth factor-1 on cartilage repair in a rat 
model of partial thickness cartilage injury. 
Methods and Materials: 5IJSUZ¾WF 4QSBHVF%BXMFZ SBUT XFSF VTFE
in a model of partial-thickness cartilage injury to assess the effect of 
intraarticular growth factors on cartilage repair. A micro-curette was 
used to create a cartilage defect on each side of the trochlear groove in 
both knees of each animal. One week later, intraarticular injections were 
begun and continued bi-weekly for 3 weeks, totaling 6 injections in each 
knee. In all animals, the left knee served as a control and was injected 
with 0.1mL sterile saline. The right knee received treatment and animals 
were randomly assigned to three groups. Group 1 (N=12) was injected 
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hormone (Prospec Labs, 250µg/ml) and group 3 (N=11) with 0.1mL 
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weeks after the injections were completed and the distal femurs were 
harvested and prepared for histology (H&E, safranin-O/fast green and 
Alcian Blue. Cartilage was graded based on the appearance of the 
surface, matrix, cell distribution and subchondral bone. 
Results: *O HSPVQ  	TBMJOF
 UIFSF XBT OP TJHOJ¾DBOU EJGGFSFODF JO
cartilage scores between the right and left knees. In addition, there was 
no difference between scores for left knees (saline) in groups 2 and 3 
and the scores for group 1. Average cartilage scores for the treatment 
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than the saline control for surface, matrix and cell distribution. There 
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and IGF-1 for any cartilage score. 
Conclusions: There is currently no effective treatment for partial-
thickness cartilage injuries. This study demonstrates that insulin-like 
growth factor-1, when injected into the joint, enhances cartilage repair 
after acute injury. Growth hormone showed a trend towards producing 
higher cartilage scores compared with a saline control but this was not 
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enhancing cartilage repair after partial-thickness chondral injury. 
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Purpose: Cell-based cartilage resurfacing (ACI) requires the ex-vivo 
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conditions have been devised to minimise phenotypic changes 
consequent to the loss of a 3D environment. However these 
conditions must be carefully assessed to avoid reactivating the 
ontogenesis of endochondral bone formation in dedifferentiated 
articular cells. Interestingly, in proliferating cultured chondrocytes, 
TGFß-1 regulates the expression of cartilage proteins but also 
contributes to hindering the differentiation potential of those ex-vivo 
expanded cells. We therefore evaluated if TGF administration could 
unlock the immature articular stage and reactivate the endochondral 
PTTJ¾DBUJPOGBUFJODVMUVSFEIVNBOBSUJDVMBSDFMMT
Methods and Materials: To this purpose human primary articular 
chondrocytes were expanded in a serum-free medium (SF), with or 
without TGFß-1 (TGF). Cell aliquots were maintained in alginate or 
as micromasses for immunocitochemistry and TUNEL analysis, or 
replated in osteogenic medium. RT-PCR and mineralization assays 
were performed after the expansion phases and the osteogenic 
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Results: In chondrogenic 3D culture systems, TGF-expanded cells 
showed a partial loss of matrix components, as assessed by Alcian 
blue, anti-aggrecan and anti- type II collagen immunocitostainings. 
Positivity was evidenced for RAGE, IHH, type X collagen, and for the 
presence of apoptotic cells, paralleling a reduction of BCL-2 levels. 
After osteogenic induction, TGF-expanded cells strongly mineralised, 
displaying an increased osteocalcin level. 
Conclusions: Thus exposure to TGFß-1 triggers the onset of the 
endochondral maturation pathway, possibly in dedifferentiated 
cells still able to undertake either the articular or the endochondral 
differentiation. The latter fate is clearly detrimental to ACI attempts. 
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Purpose: To determine the potential of subperiosteal injection 
of TGF-b1 and IGF-I, alone or in combination, to enhance in vitro 
periosteal cartilage formation and overcome the age-related decline 
in chondrogenic potential 
Methods and Materials: 111 male New Zealand white rabbits (6 months, 
1 year, or 2 years old) were anesthetized, injected (subperiosteally) 
with TGF-b1 (20 or 200ng), IGF-I (0.2 or 2 mg), TGF-b1 plus IGF-I (200 ng 
NH
PSWFIJDMFJOUIFNFEJBMQSPYJNBMUJCJB3BCCJUTXFSFTBDSJ¾DFE
after 1, 3, 5 or 7 days. Periosteal explants were harvested from the 
injection sites and cultured for 6 weeks with DMEM 10% FBS in agarose 
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O/fast green. Cartilage yield (% area) and total cartilage (mg) were 
determined by histomorphometry. Results were analyzed using 1, 2, or 
3-factor ANOVA and means comparisons where appropriate. 
Results: Injection of 200 ng TGF-b1 or the combined treatment of TGF-b1 
QMVT*('*TJHOJ¾DBOUMZJODSFBTFEDBSUJMBHFQSPEVDUJPOJOBMMBHFHSPVQT
but not at all time points (p<
 *('* BMPOF EJE OPU TJHOJ¾DBOUMZ
enhance cartilage production in any group. However, a synergistic 
effect of TGF-b1 plus IGF-I was observed in the 2 year-old rabbits in the 
combined treatment group (>2-fold increase over TGF-b1 only). 
Conclusions: These studies strongly suggest that it is possible to 
enhance the chondrogenic potential of periosteum by a one-time 
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